Estrogen Plus Progestin and Lung Cancer: Follow-up of the Women's Health Initiative Randomized Trial
Year: 2015
Type: article
Study design: Clinical Trial
Source: Clinical Lung Cancer
Institutions: The Lundquist Institute, Harbor–UCLA Medical Center, Stanford Medicine, Stanford University, Fred Hutch Cancer Center, Albert Einstein College of Medicine, Wayne State University, The Barbara Ann Karmanos Cancer Institute, University of Pittsburgh, University of Tennessee Health Science Center, University of California, San Francisco, North American Menopause Society, University at Buffalo, State University of New York
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Stanford Prevention Research Center, Amgen, Pfizer, Novartis, Brigham and Women's Hospital, Fred Hutchinson Cancer Research Center, Harvard Medical School, Ohio State University, University of Florida, University of Arizona, University of Pittsburgh, University of Iowa, Howard University, Novo Nordisk, National Institutes of Health, U.S. Public Health Service, University at Buffalo, National Heart, Lung, and Blood Institute, National Cancer Institute, NIH Clinical Center
OpenAlex ID: W1843574618